Acemetacin
The therapeutic efficacy of Potassium Citrate can be decreased when used in combination with Acemetacin.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Potassium Citrate.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Potassium Citrate.
Advertisement
Aluminum Hydroxide
Potassium Citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.
aluminum hydroxide, dried (USP)
Potassium Citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.
Benazepril
Potassium Citrate may increase the hyperkalemic activities of Benazepril.
Advertisement
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Potassium Citrate.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Potassium Citrate.
Candesartan Cilexetil
The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Potassium Citrate.
Advertisement
Captopril
Potassium Citrate may increase the hyperkalemic activities of Captopril.
Cilazapril
Potassium Citrate may increase the hyperkalemic activities of Cilazapril.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Potassium Citrate.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Potassium Citrate.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Potassium Citrate.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Potassium Citrate.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Potassium Citrate.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Potassium Citrate.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Potassium Citrate.
Enalapril
Potassium Citrate may increase the hyperkalemic activities of Enalapril.
Enalaprilat
Potassium Citrate may increase the hyperkalemic activities of Enalaprilat.
Enalaprilat Anhydrous
Potassium Citrate may increase the hyperkalemic activities of Enalaprilat.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Potassium Citrate.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Potassium Citrate.
Fosinopril
Potassium Citrate may increase the hyperkalemic activities of Fosinopril.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Potassium Citrate.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Potassium Citrate.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Potassium Citrate.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Potassium Citrate.
Imidapril
Potassium Citrate may increase the hyperkalemic activities of Imidapril.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Potassium Citrate.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Potassium Citrate.
Lisinopril
Potassium Citrate may increase the hyperkalemic activities of Lisinopril.
Lisinopril Anhydrous
Potassium Citrate may increase the hyperkalemic activities of Lisinopril.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Potassium Citrate.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Potassium Citrate.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Potassium Citrate.
Moexipril
Potassium Citrate may increase the hyperkalemic activities of Moexipril.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Potassium Citrate.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Potassium Citrate.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Potassium Citrate.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Potassium Citrate.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Potassium Citrate.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Potassium Citrate.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Potassium Citrate.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Potassium Citrate.
Perindopril
Potassium Citrate may increase the hyperkalemic activities of Perindopril.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Potassium Citrate.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Potassium Citrate.
Quinapril
Potassium Citrate may increase the hyperkalemic activities of Quinapril.
Ramipril
Potassium Citrate may increase the hyperkalemic activities of Ramipril.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Potassium Citrate.
Rescinnamine
Potassium Citrate may increase the hyperkalemic activities of Rescinnamine.
Sodium Phosphate
Potassium Citrate may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Potassium Citrate may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Potassium Citrate may increase the nephrotoxic activities of Sodium phosphate.
Spirapril
Potassium Citrate may increase the hyperkalemic activities of Spirapril.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Potassium Citrate.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Potassium Citrate.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Potassium Citrate.
Trandolapril
Potassium Citrate may increase the hyperkalemic activities of Trandolapril.
Zofenopril
Potassium Citrate may increase the hyperkalemic activities of Zofenopril.
